Report cover image

Point-of-Care Testing for Women Health Market Research by Product (Instruments/ Devices, Reagents & Kits, Consumables), by Age (Adolescent, Adult, Geriatric), by Sample Type (Serum, Plasma, White Blood, Urine, Others), by Test Type (Testosterone Test, Est

Publisher Market Research Future
Published Jul 16, 2025
Length 350 Pages
SKU # RESFT20334532

Description

The Global Point-of-Care Testing for Women’s Health Market is set to grow from USD 16,627.22 million in 2023 to USD 28,768.16 million by 2032, advancing at a compound annual growth rate of 6.26%. Women’s health Point of Care Testing (POCT) encompasses decentralized testing technologies that provide fast and accurate insights into female health-related problems, such as fertility issues and sexually transmitted diseases. In contrast to lab-based diagnostics, POCT devices offer immediate results to patients and healthcare providers. This results in instant treatment pathways, which help personalize care and increase healthcare that is accessible in underdeveloped and resource-limited areas, broadening healthcare access.
The rising prevalence of infectious diseases such as STIs, UTIs, and HPV in women underscores the critical role of point-of-care diagnostics. These tests provide fast, accurate, and accessible solutions, enabling early medical intervention. With infections contributing to complications like infertility and adverse birth outcomes, demand for efficient POC testing continues to expand across global women’s healthcare.

Major Company Development
Swiss Precision Diagnostics GmbH continues to drive innovation in women’s health diagnostics through groundbreaking product introductions and technology adoption. In August 2023, SPD launched the Clearblue Menopause Stage Indicator, the first at-home solution capable of identifying a woman’s likely menopause stage by combining urine FSH testing with age and menstrual history analysis. This breakthrough addresses a vital healthcare need, offering women greater clarity on their reproductive health. Additionally, in August 2020, SPD advanced its clinical operations by deploying the Matrix Gemini LIMS system, improving the management of pregnancy studies through streamlined sample handling, testing, and biobank operations. These developments underscore SPD’s commitment to delivering patient-centric solutions while harnessing digital tools to strengthen diagnostic efficiency and accessibility.

Major Competitors
Key competitors in the global point-of-care testing for women health market are Swiss Precision Diagnostics Gmbh (SPD), Wondfo, Church & Dwight Co., Inc., Hangzhou Singclean, Medical Products Co., Ltd., W.H.P.M., Inc., SEKISUI Diagnostics, Innovita Biological Technology Co., Ltd., Yangzhou VIOMED, Cofoe Medical Technology Co., Ltd., and Chungdo Pharm Co., Ltd.

Report Attribute Details
Market Size 2023 USD 16,627.22 Million
Market Size 2032 USD 28,768.16 Million
CAGR (2024-2032) 6.26%
Base Year 2023
Market Forecast Period 2024-2032
Historical Data 2019-2024

Market Segmentation Insights CAGR (2024-2032)
By Product: Instruments/ Devices - 7.72%, Reagents & Kits - 5.97%.
By Age: Adolescent – 8.18%, Adult – 6.20%.
By Sample Type: Serum - 5.27%, Plasma - 4.30%.
By Test Type: Testosterone Test – 4.12%, Estradiol Test – 3.53%.
By Technology: Colloidal Gold Lateral Flow Assays – 7.19%, Fluorescence Immunoassays – 5.46%.
By Application: Gestational Diabetes – 5.34%, Vaginal Infection – 4.08%.
By Distribution Channel: Offline – 5.49%, Online – 7.35%.
By End User: Hospitals – 5.42 %, Diagnostic Laboratories – 6.96%.

Regional Perspectives
North America has been the major hub of women's health products, where so many businesses have been growing with the help of innovations in various areas such as fertility, pregnancy, and STI diagnosis. Canada (USD 889.72 million) and Mexico (USD 426.32 million) follow, contributing steadily to regional growth through increasing healthcare accessibility and rising awareness of women’s health issues.
In Europe, the introduction of advanced lateral flow immunoassays as part of the technological breakthroughs in the women's health market has changed market dynamics. Germany leads the Point-of-Care Testing for Women’s Health market with USD 1,220.06 million in 2023, driven by strong healthcare adoption and technological advancements. The practice of preventive healthcare, coupled with government-backed initiatives, is fuelling cross-border demand in countries like Germany, France, and the UK. The home-based and telemedicine-supported diagnostics trend is taking root and is assuring long-term growth in the market.
Asia-Pacific stands out as the most dynamic market, recording rapid adoption across urban and rural areas. China (USD 751.65 million), India (USD 634.81 million), and Japan (USD 607.31 million) emerged as the top markets in 2023, reflecting their growing focus on women’s health and adoption of point-of-care testing solutions. With high healthcare needs, innovations in portable, low-cost testing devices are transforming women’s health diagnostics.
The Rest of the World market reflects rising adoption of POCT as a cost-effective solution to healthcare access gaps. Demand is being fueled by women’s health awareness campaigns and collaborations to distribute portable diagnostics at scale.

Table of Contents

350 Pages
1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective
2.4 Market Structure
3 Research Methodology
3.1 Overview
3.2 Data Flow
3.2.1 Data Mining Process
3.3 Purchased Database:
3.4 Secondary Sources:
3.4.1 Secondary Research Data Flow:
3.5 Primary Research:
3.5.1 Primary Research Data Flow:
3.6 Approaches For Market Size Estimation:
3.6.1 Revenue Analysis Approach
3.7 Data Forecasting
3.7.1 Data Forecasting Type
3.8 Data Modeling
3.8.1 Microeconomic Factor Analysis:
3.8.2 Data Modeling:
3.9 Teams And Analyst Contribution
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 High Prevalence Of Infectious Diseases In Women
4.2.2 Increasing Cases Of Infertility Among Women
4.2.3 Growing Strategic Initiatives Associated With The Point-of-care Testing For Women Health
4.3 Restraints
4.3.1 Inaccuracy Of Point Of Care Diagnostic Tests
4.4 Opportunity
4.4.1 Rising Awareness And Health Initiatives
4.4.2 High Cost Of Diagnostic Imaging Systems And Procedures
5 Market Factor Analysis
5.1 Porter's Five Forces Model
5.1.1 Threat Of New Entrants
5.1.2 Bargaining Power Of Suppliers
5.1.3 Threat Of Substitutes
5.1.4 Bargaining Power Of Buyers
5.1.5 Intensity Of Rivalry
5.2 Impact Of Covid-19 On The Global Point-of-care Testing For Women Health Market
5.3 Consumer Preference Analysis
5.4 Regulatory Landscape And Environmental Considerations For Colloidal Gold Products
5.4.1 Regulatory Landscape
5.4.2 Environmental Considerations For Colloidal Gold Products
5.5 Effects Of Transition Of Ivdd To Ivdr On Global Point-of-care Testing For Women Health Market
6 Global Point-of-care Testing For Women Health Market, By Product
6.1 Overview
6.2 Instruments/Devices
6.3 Reagents & Kits
6.4 Consumables
7 Global Point-of-care Testing For Women Health Market, By Age
7.1 Overview
7.2 Adolescent
7.3 Adult
7.4 Geriatric
8 Global Point-of-care Testing For Women Health Market, By Sample Type
8.1 Overview
8.2 Serum
8.3 Plasma
8.4 Whole Blood
8.5 Urine
8.6 Others
9 Global Point-of-care Testing For Women Health Market, By Test Type
9.1 Overview
9.2 Testosterone Test
9.3 Estradiol Test
9.4 Anti-müllerian Hormone Test
9.5 Prolactin Test
9.6 Progesterone Test
9.7 Follicle-stimulating Hormone Test
9.8 Luteinizing Hormone Test
9.9 Β-hcg Test
9.10 Others
10 Global Point-of-care Testing For Women Health Market, By Technology
10.1 Overview
10.2 Colloidal Gold Lateral Flow Assays
10.3 Fluorescence Immunoassays
10.4 Lab-on-a-chip
10.5 Others
11 Global Point-of-care Testing For Women Health Market, By Application
11.1 Overview
11.2 Gestational Diabetes
11.3 Vaginal Infection
11.4 Urinary Tract Infection
11.5 Cervical Cancer Or Pre-cancerous Conditions
11.6 Hemoglobin Deficiency
11.7 Breast Cancer
11.8 Thyroid Disease
11.9 Sexually Transmitted Infections
11.9.1 Chlamydia
11.9.2 Gonorrhea
11.9.3 Hiv
11.9.4 Syphilis
11.9.5 Others
11.10 Fertility Conditions
11.10.1 Polycystic Ovary Syndrome
11.10.2 Ovulation Disorders
11.10.3 Others
11.11 Pregnancy Testing
11.12 Others
12 Global Point-of-care Testing For Women Health Market, By Distribution Channel
12.1 Overview
12.2 Offline
12.2.1 Hospital Pharmacies
12.2.2 Retail Pharmacies
12.2.3 Hypermarket/Supermarket
12.3 Online
12.3.1 E-commerce Platforms
12.3.2 Online Pharmacies
13 Global Point-of-care Testing For Women Health Market, By End User
13.1 Overview
13.2 Hospitals
13.3 Diagnostic Laboratories
13.4 Home Settings
13.5 Others
14 Global Point-of-care Testing For Women Health Market, By Region
14.1 Overview
14.2 North America
14.2.1 Us
14.2.2 Canada
14.2.3 Mexico
14.3 Europe
14.3.1 Germany
14.3.2 France
14.3.3 Uk
14.3.4 Italy
14.3.5 Spain
14.3.6 Rest Of Europe
14.4 Asia-pacific
14.4.1 China
14.4.2 India
14.4.3 Japan
14.4.4 Australia
14.4.5 South Korea
14.4.6 South East Asia
14.4.6.1 Malaysia
14.4.6.2 Singapore
14.4.6.3 Thailand
14.4.6.4 Vietnam
14.4.6.5 Philippines
14.4.6.6 Indonesia
14.4.6.7 Rest Of South East Asia
14.4.7 Rest Of Asia-pacific
14.5 Rest Of The World
14.5.1 Middle East & Africa
14.5.2 South America
14.5.2.1 Brazil
14.5.2.2 Argentina
14.5.2.3 Chile
14.5.2.4 Rest Of South America
15 Competitive Landscape
15.1 Introduction
15.2 Market Share Analysis, 2023
15.3 Competitor Dashboard
15.4 Public Players Stock Summary
15.5 Comparative Analysis: Key Players Finanical
15.6 Key Developments & Growth Strategies
15.6.1 Product Launch
15.6.2 Technology Launch
15.6.3 Aquisition
15.6.4 Product Recognition
16 Company Profiles
16.1 Swiss Precision Diagnostics Gmbh - Clearblue
16.1.1 Company Overview
16.1.2 Production Overview
16.1.3 Financial Overview
16.1.4 Products Offered
16.1.5 Distribution Channel
16.1.6 Price Analysis
16.1.7 Promotion Strategy
16.1.8 Technology Analysis
16.1.9 Key Developments
16.1.10 Swot Analysis
16.1.11 Key Strategies
16.2 Wondfo
16.2.1 Company Overview
16.2.2 Production Overview
16.2.3 Financial Overview
16.2.4 Products Offered
16.2.5 Technology
16.2.6 Key Developments
16.2.7 Swot Analysis
16.2.8 Key Strategies
16.3 Church & Dwight Co., Inc. - First Response
16.3.1 Company Overview
16.3.2 Production Overview
16.3.3 Financial Overview
16.3.4 Products Offered
16.3.5 Distribution Channel
16.3.6 Price Analysis
16.3.7 Promotion
16.3.8 Technology Analysis
16.3.9 Key Developments
16.3.10 Swot Analysis
16.3.11 Key Strategies
16.4 Hangzhou Singclean Medical Products Co., Ltd.
16.4.1 Company Overview
16.4.2 Production Overview
16.4.3 Financial Overview
16.4.4 Product Offered
16.4.5 Technology Analysis
16.4.6 Key Developments
16.4.7 Key Strategies
16.5 W.H.P.M., Inc.
16.5.1 Company Overview
16.5.2 Prodcution Overview
16.5.3 Financial Overview
16.5.4 Products Offered
16.5.5 Technology Analysis
16.5.6 Key Developments
16.5.7 Key Strategies
16.6 Sekisui Diagnostics
16.6.1 Company Overview
16.6.2 Production Overview
16.6.3 Financial Overview
16.6.4 Products Offered
16.6.5 Technology Analysis
16.6.6 Key Developments
16.6.7 Swot Analysis
16.6.8 Key Strategies
16.7 Innovita Biological Technology Co., Ltd
16.7.1 Company Overview
16.7.2 Financial Overview
16.7.3 Products Offered
16.7.4 Technology Analysis
16.7.5 Key Developments
16.7.6 Key Strategies
16.8 Yangzhou Viomed
16.8.1 Company Overview
16.8.2 Production Overview
16.8.3 Financial Overview
16.8.4 Products Offered
16.8.5 Technology Analysis
16.8.6 Key Developments
16.8.7 Key Strategies
16.9 Cofoe Medical Technology Co., Ltd.
16.9.1 Company Overview
16.9.2 Production Overview
16.9.3 Financial Overview
16.9.4 Products Offered
16.9.5 Key Developments
16.9.6 Technology Analysis
16.9.7 Swot Analysis
16.9.8 Key Strategies
16.10 Chungdo Pharm Co., Ltd.
16.10.1 Company Overview
16.10.2 Production Overview
16.10.3 Financial Overview
16.10.4 Proudcts Offered
16.10.5 Technology Analysis
16.10.6 Key Developments
16.10.7 Key Strategies
16.11 Econas Biopharmaceutical Technology Co., Ltd.
16.11.1 Company Overview
16.11.2 Production Overview
16.11.3 Financial Overview
16.11.4 Products Offered
16.11.5 Technology Analysis
16.11.6 Key Developments
16.11.7 Swot Analysis
16.11.8 Key Strategies
16.12 Easy Healthcare Corporation
16.12.1 Company Overview
16.12.2 Production Overview
16.12.3 Financial Overview
16.12.4 Products Offered
16.12.5 Technology
16.12.6 Key Developments
16.12.7 Key Strategies
17 Data Citations
List Of Tables
Table 1 Qfd Modeling For Market Share Assessment
Table 2 Difference Between Ivdd & Ivdr
Table 3 Global Point-of-care Testing For Women Health Market, By Product, 2019–2032 (Usd Million)
Table 4 Global Point-of-care Testing For Women Health Market, For Instruments/Devices, By Region, 2019–2032 (Usd Million)
Table 5 Global Point-of-care Testing For Women Health Market, For Reagents & Kits, By Region, 2019–2032 (Usd Million)
Table 6 Global Point-of-care Testing For Women Health Market, For Consumables, By Region, 2019–2032 (Usd Million)
Table 7 Global Point-of-care Testing For Women Health Market, By Age, 2019–2032 (Usd Million)
Table 8 Global Point-of-care Testing For Women Health Market, For Adolescent, By Region, 2019–2032 (Usd Million)
Table 9 Global Point-of-care Testing For Women Health Market, For Adult, By Region, 2019–2032 (Usd Million)
Table 10 Global Point-of-care Testing For Women Health Market, For Geriatric, By Region, 2019–2032 (Usd Million)
Table 11 Global Point-of-care Testing For Women Health Market, By Sample Type, 2019–2032 (Usd Million)
Table 12 Global Point-of-care Testing For Women Health Market, For Serum, By Region, 2019–2032 (Usd Million)
Table 13 Global Point-of-care Testing For Women Health Market, For Plasma, By Region, 2019–2032 (Usd Million)
Table 14 Global Point-of-care Testing For Women Health Market, For Whole Blood, By Region, 2019–2032 (Usd Million)
Table 15 Global Point-of-care Testing For Women Health Market, For Urine, By Region, 2019–2032 (Usd Million)
Table 16 Global Point-of-care Testing For Women Health Market, For Others, By Region, 2019–2032 (Usd Million)
Table 17 Global Point-of-care Testing For Women Health Market, By Test Type, 2019–2032 (Usd Million)
Table 18 Global Point-of-care Testing For Women Health Market, For Testosterone Test, By Region, 2019–2032 (Usd Million)
Table 19 Global Point-of-care Testing For Women Health Market, For Estradiol Test, By Region, 2019–2032 (Usd Million)
Table 20 Global Point-of-care Testing For Women Health Market, For Anti-müllerian Hormone Test, By Region, 2019–2032 (Usd Million)
Table 21 Global Point-of-care Testing For Women Health Market, For Prolactin Test, By Region, 2019–2032 (Usd Million)
Table 22 Global Point-of-care Testing For Women Health Market, For Progesterone Test, By Region, 2019–2032 (Usd Million)
Table 23 Global Point-of-care Testing For Women Health Market, For Follicle-stimulating Hormone Test, By Region, 2019–2032 (Usd Million)
Table 24 Global Point-of-care Testing For Women Health Market, For Luteinizing Hormone Test, By Region, 2019–2032 (Usd Million)
Table 25 Global Point-of-care Testing For Women Health Market, For Β-hcg Test, By Region, 2019–2032 (Usd Million)
Table 26 Global Point-of-care Testing For Women Health Market, For Others, By Region, 2019–2032 (Usd Million)
Table 27 Global Point-of-care Testing For Women Health Market, By Technology, 2019–2032 (Usd Million)
Table 28 Global Point-of-care Testing For Women Health Market, For Colloidal Gold Lateral Flow Assays, By Region, 2019–2032 (Usd Million)
Table 29 Global Point-of-care Testing For Women Health Market, For Fluorescence Immunoassays, By Region, 2019–2032 (Usd Million)
Table 30 Global Point-of-care Testing For Women Health Market, For Lab-on-a-chip, By Region, 2019–2032 (Usd Million)
Table 31 Global Point-of-care Testing For Women Health Market, For Others, By Region, 2019–2032 (Usd Million)
Table 32 Global Point-of-care Testing For Women Health Market, By Application, 2019–2032 (Usd Million)
Table 33 Global Point-of-care Testing For Women Health Market, For Gestational Diabetes, By Region, 2019–2032 (Usd Million)
Table 34 Global Point-of-care Testing For Women Health Market, For Vaginal Infection, By Region, 2019–2032 (Usd Million)
Table 35 Global Point-of-care Testing For Women Health Market, For Urinary Tract Infection, By Region, 2019–2032 (Usd Million)
Table 36 Global Point-of-care Testing For Women Health Market, For Cervical Cancer Or Pre-cancerous Conditions, By Region, 2019–2032 (Usd Million)
Table 37 Global Point-of-care Testing For Women Health Market, For Hemoglobin Deficiency, By Region, 2019–2032 (Usd Million)
Table 38 Global Point-of-care Testing For Women Health Market, For Breast Cancer, By Region, 2019–2032 (Usd Million)
Table 39 Global Point-of-care Testing For Women Health Market, For Thyroid Disease, By Region, 2019–2032 (Usd Million)
Table 40 Global Point-of-care Testing For Women Health Market, For Sexually Transmitted Infections, By Region, 2019–2032 (Usd Million)
Table 41 Global Point-of-care Testing For Women Health Market, For Sexually Transmitted Infections, By Type, 2019–2032 (Usd Million)
Table 42 Global Point-of-care Testing For Women Health Market, For Chlamydia, By Region, 2019–2032 (Usd Million)
Table 43 Global Point-of-care Testing For Women Health Market, For Gonorrhea, By Region, 2019–2032 (Usd Million)
Table 44 Global Point-of-care Testing For Women Health Market, For Hiv, By Region, 2019–2032 (Usd Million)
Table 45 Global Point-of-care Testing For Women Health Market, For Syphilis, By Region, 2019–2032 (Usd Million)
Table 46 Global Point-of-care Testing For Women Health Market, For Others, By Region, 2019–2032 (Usd Million)
Table 47 Global Point-of-care Testing For Women Health Market, For Fertility Conditions, By Region, 2019–2032 (Usd Million)
Table 48 Global Point-of-care Testing For Women Health Market, For Fertility Conditions, By Type, 2019–2032 (Usd Million)
Table 49 Global Point-of-care Testing For Women Health Market, For Polycystic Ovary Syndrome, By Region, 2019–2032 (Usd Million)
Table 50 Global Point-of-care Testing For Women Health Market, For Ovulation Disorders, By Region, 2019–2032 (Usd Million)
Table 51 Global Point-of-care Testing For Women Health Market, For Others, By Region, 2019–2032 (Usd Million)
Table 52 Global Point-of-care Testing For Women Health Market, For Pregnancy Testing, By Region, 2019–2032 (Usd Million)
Table 53 Global Point-of-care Testing For Women Health Market, For Others, By Region, 2019–2032 (Usd Million)
Table 54 Global Point-of-care Testing For Women Health Market, By Distribution Channel, 2019–2032 (Usd Million)
Table 55 Global Point-of-care Testing For Women Health Market, For Offline, By Region, 2019–2032 (Usd Million)
Table 56 Global Point-of-care Testing For Women Health Market, For Offline, By Type, 2019–2032 (Usd Million)
Table 57 Global Point-of-care Testing For Women Health Market, For Hospital Pharmacies, By Region, 2019–2032 (Usd Million)
Table 58 Global Point-of-care Testing For Women Health Market, For Retail Pharmacies, By Region, 2019–2032 (Usd Million)
Table 59 Global Point-of-care Testing For Women Health Market, For Hypermarket/Supermarket, By Region, 2019–2032 (Usd Million)
Table 60 Global Point-of-care Testing For Women Health Market, For Online, By Region, 2019–2032 (Usd Million)
Table 61 Global Point-of-care Testing For Women Health Market, For Online, By Type, 2019–2032 (Usd Million)
Table 62 Global Point-of-care Testing For Women Health Market, For E-commerce Platforms, By Region, 2019–2032 (Usd Million)
Table 63 Global Point-of-care Testing For Women Health Market, For Online Pharmacies, By Region, 2019–2032 (Usd Million)
Table 64 Global Point-of-care Testing For Women Health Market, By End User, 2019–2032 (Usd Million)
Table 65 Global Point-of-care Testing For Women Health Market, For Hospitals, By Region, 2019–2032 (Usd Million)
Table 66 Global Point-of-care Testing For Women Health Market, For Diagnostic Laboratories, By Region, 2019–2032 (Usd Million)
Table 67 Global Point-of-care Testing For Women Health Market, For Home Settings, By Region, 2019–2032 (Usd Million)
Table 68 Global Point-of-care Testing For Women Health Market, For Others, By Region, 2019–2032 (Usd Million)
Table 69 Global Point-of-care Testing For Women Health Market, By Region, 2019–2032 (Usd Million)
Table 70 North America: Point-of-care Testing For Women Health Market, By Country, 2019–2032 (Usd Million)
Table 71 North America: Point-of-care Testing For Women Health Market, By Product, 2019–2032 (Usd Million)
Table 72 North America: Point-of-care Testing For Women Health Market, By Age, 2019–2032 (Usd Million)
Table 73 North America: Point-of-care Testing For Women Health Market, By Sample Type, 2019–2032 (Usd Million)
Table 74 North America: Point-of-care Testing For Women Health Market, By Test Type, 2019–2032 (Usd Million)
Table 75 North America: Point-of-care Testing For Women Health Market, By Technology, 2019–2032 (Usd Million)
Table 76 North America: Point-of-care Testing For Women Health Market, By Application, 2019–2032 (Usd Million)
Table 77 North America: Point-of-care Testing For Women Health Market, For Sexually Transmitted Infections, By Type, 2019–2032 (Usd Million)
Table 78 North America: Point-of-care Testing For Women Health Market, For Fertility Conditions, By Type, 2019–2032 (Usd Million)
Table 79 North America: Point-of-care Testing For Women Health Market, By Distribution Channel, 2019–2032 (Usd Million)
Table 80 North America: Point-of-care Testing For Women Health Market, For Offline, By Type, 2019–2032 (Usd Million)
Table 81 North America: Point-of-care Testing For Women Health Market, For Online, By Type, 2019–2032 (Usd Million)
Table 82 North America: Point-of-care Testing For Women Health Market, By End User, 2019–2032 (Usd Million)
Table 83 Us: Point-of-care Testing For Women Health Market, By Product, 2019–2032 (Usd Million)
Table 84 Us: Point-of-care Testing For Women Health Market, By Age, 2019–2032 (Usd Million)
Table 85 Us: Point-of-care Testing For Women Health Market, By Sample Type, 2019–2032 (Usd Million)
Table 86 Us: Point-of-care Testing For Women Health Market, By Test Type, 2019–2032 (Usd Million)
Table 87 Us: Point-of-care Testing For Women Health Market, By Technology, 2019–2032 (Usd Million)
Table 88 Us: Point-of-care Testing For Women Health Market, By Application, 2019–2032 (Usd Million)
Table 89 Us: Point-of-care Testing For Women Health Market, For Sexually Transmitted Infections, By Type, 2019–2032 (Usd Million)
Table 90 Us: Point-of-care Testing For Women Health Market, For Fertility Conditions, By Type, 2019–2032 (Usd Million)
Table 91 Us: Point-of-care Testing For Women Health Market, By Distribution Channel, 2019–2032 (Usd Million)
Table 92 Us: Point-of-care Testing For Women Health Market, For Offline, By Type, 2019–2032 (Usd Million)
Table 93 Us: Point-of-care Testing For Women Health Market, For Online, By Type, 2019–2032 (Usd Million)
Table 94 Us: Point-of-care Testing For Women Health Market, By End User, 2019–2032 (Usd Million)
Table 95 Canada: Point-of-care Testing For Women Health Market, By Product, 2019–2032 (Usd Million)
Table 96 Canada: Point-of-care Testing For Women Health Market, By Age, 2019–2032 (Usd Million)
Table 97 Canada: Point-of-care Testing For Women Health Market, By Sample Type, 2019–2032 (Usd Million)
Table 98 Canada: Point-of-care Testing For Women Health Market, By Test Type, 2019–2032 (Usd Million)
Table 99 Canada: Point-of-care Testing For Women Health Market, By Technology, 2019–2032 (Usd Million)
Table 100 Canada: Point-of-care Testing For Women Health Market, By Application, 2019–2032 (Usd Million)
Table 101 Canada: Point-of-care Testing For Women Health Market, For Sexually Transmitted Infections, By Type, 2019–2032 (Usd Million)
Table 102 Canada: Point-of-care Testing For Women Health Market, For Fertility Conditions, By Type, 2019–2032 (Usd Million)
Table 103 Canada: Point-of-care Testing For Women Health Market, By Distribution Channel, 2019–2032 (Usd Million)
Table 104 Canada: Point-of-care Testing For Women Health Market, For Offline, By Type, 2019–2032 (Usd Million)
Table 105 Canada: Point-of-care Testing For Women Health Market, For Online, By Type, 2019–2032 (Usd Million)
Table 106 Canada: Point-of-care Testing For Women Health Market, By End User, 2019–2032 (Usd Million)
Table 107 Mexico: Point-of-care Testing For Women Health Market, By Product, 2019–2032 (Usd Million)
Table 108 Mexico: Point-of-care Testing For Women Health Market, By Age, 2019–2032 (Usd Million)
Table 109 Mexico: Point-of-care Testing For Women Health Market, By Sample Type, 2019–2032 (Usd Million)
Table 110 Mexico: Point-of-care Testing For Women Health Market, By Test Type, 2019–2032 (Usd Million)
Table 111 Mexico: Point-of-care Testing For Women Health Market, By Technology, 2019–2032 (Usd Million)
Table 112 Mexico: Point-of-care Testing For Women Health Market, By Application, 2019–2032 (Usd Million)
Table 113 Mexico: Point-of-care Testing For Women Health Market, For Sexually Transmitted Infections, By Type, 2019–2032 (Usd Million)
Table 114 Mexico: Point-of-care Testing For Women Health Market, For Fertility Conditions, By Type, 2019–2032 (Usd Million)
Table 115 Mexico: Point-of-care Testing For Women Health Market, By Distribution Channel, 2019–2032 (Usd Million)
Table 116 Mexico: Point-of-care Testing For Women Health Market, For Offline, By Type, 2019–2032 (Usd Million)
Table 117 Mexico: Point-of-care Testing For Women Health Market, For Online, By Type, 2019–2032 (Usd Million)
Table 118 Mexico: Point-of-care Testing For Women Health Market, By End User, 2019–2032 (Usd Million)
Table 119 Europe: Point-of-care Testing For Women Health Market, By Country, 2019–2032 (Usd Million)
Table 120 Europe: Point-of-care Testing For Women Health Market, By Product, 2019–2032 (Usd Million)
Table 121 Europe: Point-of-care Testing For Women Health Market, By Age, 2019–2032 (Usd Million)
Table 122 Europe: Point-of-care Testing For Women Health Market, By Sample Type, 2019–2032 (Usd Million)
Table 123 Europe: Point-of-care Testing For Women Health Market, By Test Type, 2019–2032 (Usd Million)
Table 124 Europe: Point-of-care Testing For Women Health Market, By Technology, 2019–2032 (Usd Million)
Table 125 Europe: Point-of-care Testing For Women Health Market, By Application, 2019–2032 (Usd Million)
Table 126 Europe: Point-of-care Testing For Women Health Market, For Sexually Transmitted Infections, By Type, 2019–2032 (Usd Million)
Table 127 Europe: Point-of-care Testing For Women Health Market, For Fertility Conditions, By Type, 2019–2032 (Usd Million)
Table 128 Europe: Point-of-care Testing For Women Health Market, By Distribution Channel, 2019–2032 (Usd Million)
Table 129 Europe: Point-of-care Testing For Women Health Market, For Offline, By Type, 2019–2032 (Usd Million)
Table 130 Europe: Point-of-care Testing For Women Health Market, For Online, By Type, 2019–2032 (Usd Million)
Table 131 Europe: Point-of-care Testing For Women Health Market, By End User, 2019–2032 (Usd Million)
Table 132 Germany: Point-of-care Testing For Women Health Market, By Product, 2019–2032 (Usd Million)
Table 133 Germany: Point-of-care Testing For Women Health Market, By Age, 2019–2032 (Usd Million)
Table 134 Germany: Point-of-care Testing For Women Health Market, By Sample Type, 2019–2032 (Usd Million)
Table 135 Germany: Point-of-care Testing For Women Health Market, By Test Type, 2019–2032 (Usd Million)
Table 136 Germany: Point-of-care Testing For Women Health Market, By Technology, 2019–2032 (Usd Million)
Table 137 Germany: Point-of-care Testing For Women Health Market, By Application, 2019–2032 (Usd Million)
Table 138 Germany: Point-of-care Testing For Women Health Market, For Sexually Transmitted Infections, By Type, 2019–2032 (Usd Million)
Table 139 Germany: Point-of-care Testing For Women Health Market, For Fertility Conditions, By Type, 2019–2032 (Usd Million)
Table 140 Germany: Point-of-care Testing For Women Health Market, By Distribution Channel, 2019–2032 (Usd Million)
Table 141 Germany: Point-of-care Testing For Women Health Market, For Offline, By Type, 2019–2032 (Usd Million)
Table 142 Germany: Point-of-care Testing For Women Health Market, For Online, By Type, 2019–2032 (Usd Million)
Table 143 Germany: Point-of-care Testing For Women Health Market, By End User, 2019–2032 (Usd Million)
Table 144 France: Point-of-care Testing For Women Health Market, By Product, 2019–2032 (Usd Million)
Table 145 France: Point-of-care Testing For Women Health Market, By Age, 2019–2032 (Usd Million)
Table 146 France: Point-of-care Testing For Women Health Market, By Sample Type, 2019–2032 (Usd Million)
Table 147 France: Point-of-care Testing For Women Health Market, By Test Type, 2019–2032 (Usd Million)
Table 148 France: Point-of-care Testing For Women Health Market, By Technology, 2019–2032 (Usd Million)
Table 149 France: Point-of-care Testing For Women Health Market, By Application, 2019–2032 (Usd Million)
Table 150 France: Point-of-care Testing For Women Health Market, For Sexually Transmitted Infections, By Type, 2019–2032 (Usd Million)
List Of Figures
Figure 1 Global Point-of-care Testing For Women Health Market: Structure
Figure 2 Global Point-of-care Testing For Women Health Market: Market Growth Factor Analysis (2023-2032)
Figure 3 Driver Impact Analysis (2024-2032)
Figure 4 Restraint Impact Analysis (2024-2032)
Figure 5 Porter's Five Forces Analysis: Global Point-of-care Testing For Women Health Market
Figure 6 Global Point-of-care Testing For Women Health Market, By Product, 2023 & 2032 (Usd Million)
Figure 7 Global Point-of-care Testing For Women Health Market Share (%), By Product, 2023
Figure 8 Global Point-of-care Testing For Women Health Market, By Age, 2023 & 2032 (Usd Million)
Figure 9 Global Point-of-care Testing For Women Health Market Share (%), By Age, 2023
Figure 10 Global Point-of-care Testing For Women Health Market, By Sample Type, 2023 & 2032 (Usd Million)
Figure 11 Global Point-of-care Testing For Women Health Market Share (%), By Sample Type, 2023
Figure 12 Global Point-of-care Testing For Women Health Market, By Test Type, 2023 & 2032 (Usd Million)
Figure 13 Global Point-of-care Testing For Women Health Market Share (%), By Test Type, 2023
Figure 14 Global Point-of-care Testing For Women Health Market, By Test Type, 2023 & 2032 (Usd Million)
Figure 15 Global Point-of-care Testing For Women Health Market Share (%), By Technology, 2023
Figure 16 Global Point-of-care Testing For Women Health Market, By Application, 2023 & 2032 (Usd Million)
Figure 17 Global Point-of-care Testing For Women Health Market Share (%), By Application, 2023
Figure 18 Global Point-of-care Testing For Women Health Market, By Distribution Channel, 2023 & 2032 (Usd Million)
Figure 19 Global Point-of-care Testing For Women Health Market Share (%), By Distribution Channel, 2023
Figure 20 Global Point-of-care Testing For Women Health Market, By End User, 2023 & 2032 (Usd Million)
Figure 21 Global Point-of-care Testing For Women Health Market Share (%), By End User, 2023
Figure 22 Global Point-of-care Testing For Women Health Market, By Region, 2023 & 2032 (Usd Million)
Figure 23 Global Point-of-care Testing For Women Health Market Share (%), By Region, 2023
Figure 24 North America Market Analysis: Point-of-care Testing For Women Health Market, 2019-2032 (Usd Million)
Figure 25 North America: Point-of-care Testing For Women Health Market, By Country, 2023 & 2032 (Usd Million)
Figure 26 North America: Point-of-care Testing For Women Health Market Share (%), By Country, 2023
Figure 27 Europe Market Analysis: Point-of-care Testing For Women Health Market, 2019-2032 (Usd Million)
Figure 28 Europe: Point-of-care Testing For Women Health Market, By Country, 2023 & 2032 (Usd Million)
Figure 29 Europe: Point-of-care Testing For Women Health Market Share (%), By Country, 2023
Figure 30 Asia-pacific Market Analysis: Point-of-care Testing For Women Health Market, 2019-2032 (Usd Million)
Figure 31 Asia-pacific: Point-of-care Testing For Women Health Market Share, By Country, 2023 & 2032 (Usd Million)
Figure 32 Asia-pacific: Point-of-care Testing For Women Health Market Share, By Country, 2023 (%)
Figure 33 South East Asia: Point-of-care Testing For Women Health Market Share, By Country, 2023 & 2032 (Usd Million)
Figure 34 South East Asia: Point-of-care Testing For Women Health Market Share, By Country, 2023 (%)
Figure 35 Rest Of The World Market Analysis: Point-of-care Testing For Women Health Market, 2019-2032 (Usd Million)
Figure 36 Rest Of The World: Point-of-care Testing For Women Health Market Share, By Country, 2023 & 2032 (Usd Million)
Figure 37 Rest Of The World: Point-of-care Testing For Women Health Market Share, By Country, 2023 (%)
Figure 38 South America: Point-of-care Testing For Women Health Market Share, By Country, 2023 & 2032 (Usd Million)
Figure 39 South America: Point-of-care Testing For Women Health Market Share, By Country, 2023 (%)
Figure 40 Global Point-of-care Testing For Women Health Market Players: Competitive Analysis, 2023
Figure 41 Competitor Dashboard: Global Point-of-care Testing For Women Health Market
Figure 42 Swiss Precision Diagnostics Gmbh: Swot Analysis
Figure 43 Wondfo: Swot Analysis
Figure 44 Church & Dwight Co., Inc.: Financial Overview Snapshot
Figure 45 Church & Dwight Co., Inc.: Swot Analysis
Figure 46 Sekisui Diagnostics: Swot Analysis
Figure 47 Cofoe Medical Technology Co., Ltd.: Swot Analysis
Figure 48 Econas Biopharmaceutical Technology Co., Ltd.: Swot Analysis

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us